drugset / Trial / NCT06250088

Emdogain Adjunctive to Autotransplantation

NCT06250088

Phase 4 Unknown 20 enrolled Universidad Complutense de Madrid
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this randomized clinical trial is to compare the adjunctive use of enamel matrix derivatives in the treatment of tooth autotransplantation in terms of clinical attachment level. The main question it aims to answer. What is the benefit, in terms of clinical attachment level and probing depths, of using enamel matrix derivatives adjunctive to tooth autotransplantation? Participants will be subjected to a digitally guided surgery of tooth autotransplantation. The protocol of the test group will be supplemented with the application of enamel matrix derivatives before the placement of the transplanted tooth into the surgically produced alveolus.

Timeline

Start
2024-03-12
Primary completion
2025-06-01
Completion
2026-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Emdogain Other / unclassified

Indications

No indication recorded.